Bio...don't get too discouraged yet. The shares might not rebound the way everyone guessed pre PDUFA, but post PDUFA I am confident we will see increases on share price.
DF & WP have a lot of money tied up in this deal & if you look at what they are financing, TLON is the only stock below $2.00 they currently finance in the biotech sector. So, hold on to that thought until PDUFA comes.
Bio---I'm with ya on that point for sure---I was hoping we would have a strong run up---right into the announcement---but with a micro-cap the volume just wasn't there to fuel the run and people started booking profits----normal behavior, and I don't think the price action foretells the outcome here---it just describes human behavior----most people have learned to book profits---sell into the move---and re-load on the pull back---especially in the (sc) bio sector. I wouldn't let the price action overwhelm the DD we have developed-----I always focus on the fact that the patients this drug delivery system is intended for really have no other hope---the risk is no worse than the SOC--Vincristine---all the oncologists on the ODAC voted yes---I think we will win here. GLTY
Market Data 
Markets 
AI
